tirzepatide starting dose 2.5 mg Dosage Chart: Weekly Dosing Schedule Explained What is the Tirzepatide Starting
Description
Chemical & Handling Information Type: Synthetic dual incretin receptor agonist Targets: GIP receptor and GLP-1 receptor Appearance: White to off-white lyophilized powder Specifications Peptide: Tirzepatide Amount: 60 mg per vial Form: Lyophilized powder Purity: ?99% (HPLC)
In the SURMOUNT-1 trial, participants on 10mg lost an average of 21.4% of their body weight over 72 weeks, approximately 49 pounds
(verified owner) I lost 13 pounds in 4 weeks
The difference is fundamental
